Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study

Safety and effectiveness of rapid-acting intramuscular olanzapine for agitation associated with schizophrenia – Japan postmarketing surveillance study

Hideaki Katagiri,1 Masanori Taketsuna,2 Shinpei Kondo,3 Kenta Kajimoto,4 Etsuko Aoi,5 Yuka Tanji1 1Bio Medicine, 2Statistical Sciences, 3Post Marketing Study Management, 4Scientific Communications, Medicines Development Unit Japan, 5Global Patient Safety Japan, Quality and Patient Safety, Eli Lilly...

Full description

Bibliographic Details
Main Authors: Katagiri H, Taketsuna M, Kondo S, Kajimoto K, Aoi E, Tanji Y
Format: Article
Language:English
Published: Dove Medical Press 2018-01-01
Series:Neuropsychiatric Disease and Treatment
Subjects:
Agitation
Japanese
Postmarketing Surveillance Study
Rapid-Acting Intramuscular Olanzapine
Schizophrenia
Online Access:https://www.dovepress.com/safety-and-effectiveness-of-rapid-acting-intramuscular-olanzapine-for--peer-reviewed-article-NDT

Internet

https://www.dovepress.com/safety-and-effectiveness-of-rapid-acting-intramuscular-olanzapine-for--peer-reviewed-article-NDT

Similar Items